Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07367542
NA

Effect of Esketamine on Perioperative Negative Emotions in Patients Undergoing Breast Cancer Surgery

Sponsor: Chinese PLA General Hospital

View on ClinicalTrials.gov

Summary

A Dual-Center, Randomized, Controlled, Blinded, Prospective Study on the Effects of Esketamine on Perioperative Negative Emotions in Patients Undergoing Breast Cancer Surgery

Official title: Effect of Continuous Intraoperative Esketamine Infusion on Perioperative Negative Emotions in Patients Undergoing Breast Cancer Surgery: A Randomized Controlled Trial

Key Details

Gender

FEMALE

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

218

Start Date

2026-01-17

Completion Date

2027-02-01

Last Updated

2026-01-27

Healthy Volunteers

No

Interventions

DRUG

Esketamine 0.3mg/kg

A single dose of 0.3 mg/kg esketamine is administered intravenously during anesthesia induction, with the infusion completed over 40 minutes.

DRUG

Normal Saline

Receiving the same volume of normal saline during induction of anesthesia during the same time

Locations (1)

First Medical center of Chinese PLA General Hospital

Beijing, China